4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-017272
SVP, Business Development sold 20,465 shares at an average $18.28 ($374,017)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Birznieks Gunther SVP, Business Development | 2021-03-01 | Sale | −3,845 | $18.66 | $71,744 | 188,328 | D: show line 1 in the form |
| Birznieks Gunther SVP, Business Development | 2021-03-02 | Sale | −16,620 | $18.19 | $302,273 | 171,708 | D: show line 2 in the form |
| Open-market sales · 20,465 sh · avg $18.28 · $374,017 | |||||||
Loading xslF345X03/doc4.xml…